Compare Bank of Nova Scotia (BNS) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs Ginkgo Bioworks Holdings Inc — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Bank of Nova Scotia is far larger — about 214.2× Ginkgo Bioworks Holdings Inc's market cap, and Bank of Nova Scotia pays a 3.64% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| BNS | DNA | |
|---|---|---|
Market Cap | $108.32B | $505.73M |
Sector | Financials | Health |
52-Week High | $90.29 | $16.14 |
52-Week Low | $56.41 | $5.48 |
Dividend Yield | 3.64% | — |
Enterprise Value | — | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
